Pro-Apoptotic Effects of Dithiocarbamate on Oral Squamous Cell Carcinoma HSC-3 and HSC-4 Cell Lines 1 Department of Oral Biology Faculty of Dentistry Universitas YARSI, Indonesia Abstract Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive cancer in the head and neck region, leading to high morbidity and mortality. Current treatments, including chemotherapy, radiation, and surgery are often limited by severe side effects and the emergence of chemoresistant cancer cells. Dithiocarbamate (DTC) has exhibited various chemical and biological activities, including antibacterial, antifungal, and anticancer effects. This study aims to explore the anticancer potential of DTC on oral cancer cells. Human OSCC cell lines HSC-3 and HSC-4 were utilized. Cytotoxic activities were measured using the MTT assay. Apoptotic cell numbers were evaluated through flow cytometry analysis. The expression levels of pro-apoptotic genes PUMA and Caspase-9 were assessed using Quantitative RT-PCR. Statistical analysis was performed using one-way ANOVA followed by Dunnett^s post hoc test to compare the means between treatment and control groups. Our results demonstrated that DTC decreased the viability of oral cancer cells in a dose- and time-dependent manner. Flow cytometry showed an increase in apoptotic cells, supported by significant upregulations of PUMA and Caspase-9 (p<0.05). DTC demonstrates significant pro-apoptotic activity against HSC-3 and HSC-4 cell lines, highlighting its potential as a new chemotherapeutic agent for OSCC. Keywords: Apoptosis, Dithiocarbamate, HSC-3, HSC-4, OSCC Topic: Pharmacology |
ICDenTeMS 2024 Conference | Conference Management System |